Geron Corp (NASDAQ:GERN)

3.79
Delayed Data
As of Apr 20
 +0.10 / +2.71%
Today’s Change
1.74
Today|||52-Week Range
6.68
+110.56%
Year-to-Date

Today’s Trading

Previous close3.69
Today’s open3.75
Day’s range3.54 - 3.80
Volume3,315,729
Average volume (3 months)5,526,377
Market cap$445.8M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book3.64

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc-0.03-1.26%
BLCMBellicum Pharmaceuti...-0.02-0.27%
EDGEEdge Therapeutics In...-0.06-5.00%
AGENAgenus Inc+0.02+0.53%
Data as of 8:00pm ET, 04/20/2018

Financials

Next reporting dateMay 11, 2018
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts